Amgen Reports Second Quarter 2021 Financial Results
Amgen today announced financial results for the second quarter of 2021. Key results include: Total revenues increased 5% to $6.5 billion in comparison to the second quarter of 2020, driven by higher unit demand, partially offset by lower net selling prices. Product sales increased 3% globally, driven by double digit volume growth across a number of our products including Prolia ® Repatha ® and our biosimilar …
– Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2021. Key results include: Total revenues increased 5% to $6.5 billion in comparison to the second quarter of 2020, driven by higher unit demand, partially offset by lower net selling prices.
China
Puerto-rico
Japan
Ohio
United-states
North-carolina
Philadelphia
Pennsylvania
Japanese
Neulasta-onpro
Trish-rowland
Roberta-bradway